Mostrar el registro sencillo del ítem

Association between SARS-CoV-2 infection and neuropsychiatric manifestations

dc.creatorLlorente Vidrio, Aranzaes_ES
dc.creatorNicolini, Humbertoes_ES
dc.creatorTovilla Zarate, Carloses_ES
dc.creatorGonzales Castro, Thelmaes_ES
dc.creatorJuárez Rojop, Iselaes_ES
dc.creatorMartínez Magaña, Jaimees_ES
dc.creatorMartínez López, Nicoláses_ES
dc.creatorGenis Mendoza, Alma Deliaes_ES
dc.date2022
dc.date.accessioned2025-01-24T17:44:26Z
dc.date.available2025-01-24T17:44:26Z
dc.date.issued2022
dc.identifierOE30IC22es_ES
dc.identifier.issn2673-8112
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/8208
dc.identifier.urihttps://doi.org/10.3390/covid2090094
dc.descriptionCoronaviruses are neurotropic viruses capable of entering the brain through various mechanisms and generating an important inflammatory response that is capable of triggering neu ropsychiatric manifestations. Several reports describe the appearance of different conditions, such as sleep problems, anxiety and depression disorders, acute psychotic disorders, encephalitis, and delirium, among others, associated with COVID-19 infection. We performed a literature review in PubMed, Springer, Nature, MDPI, and other scientific journals on the relationship between COVID-19 infection with the development and aggravation of neuropsychiatric manifestations explained by molecular changes secondary to SARS-CoV-2 where it was found that there is a relationship between the virus and the development of these manifestations. Prospective neuropsychiatric follow-up of people exposed to SARS-CoV-2 at different points in their lives, as well as their neuroimmunological status, is necessary to fully understand the long-term impact of COVID-19 on mental health. It is required to identify the risk of developing neuropsychiatric problems due to COVID-19 infection to provide better medical care from a multidisciplinary team and improve the prognosis of these patients as well as the treatment of long-term sequelae.es_ES
dc.formatPDFes_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relation2(9):1270-1286
dc.rightsAcceso Cerradoes_ES
dc.titleAssociation between SARS-CoV-2 infection and neuropsychiatric manifestationses_ES
dc.typeArtículoes_ES
dc.contributor.affiliationLaboratory of Genomics of Psychiatric and Neurodegenerative Diseases, National Institute of Genomic Medicine, Mexico City 14610, Mexico
dc.contributor.emailadgenis@inmegen.gob.mx
dc.relation.jnabreviadoCOVID
dc.relation.journalCOVID
dc.identifier.placeSuiza
dc.date.published2022
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
dc.identifier.doi10.3390/covid2090094
dc.subject.kwCOVID-19
dc.subject.kwCoronaviruses
dc.subject.kwPsychosis
dc.subject.kwMental health
dc.subject.kwPsychiatric disorder
dc.subject.kwSequel
dc.subject.kwInflammation
dc.subject.kwCytokine storm
dc.subject.kwNeurocovid


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem